Clinical Signs definition

Clinical Signs means changes in a Pet’s normal healthy state, bodily function or behavior observed by you, a Veterinarian, or other observer.
Sample 1Sample 2Sample 3
Clinical Signs means any changes to the Insured Pet’s normal healthy state.
Sample 1Sample 2Sample 3
Clinical Signs means the objective evidence of disease.
Sample 1Sample 2

Examples of Clinical Signs in a sentence

  • If Your Pet has NOT shown Clinical Symptoms or Clinical Signs of a Chronic and/ or Recurrent Condition(s) for a period of 24 months prior to the Policy Coverage Effective Date, We may consider this Condition NOT pre-existing by definition and allow the Medical Condition to be eligible for Benefits.

  • If a Pet has been diagnosed, treated, or was showing Clinical Signs of renal disease prior to the end of the Waiting Period, any renal Treatments and Medications are not covered, as well as any related conditions that may develop.

  • However, for the purposes of this exclusion, temporary conditions that started prior to the end of the Waiting Period, or the condition manifests after the Original Start Date, and the condition has not shown any Clinical Signs for a period of twelve (12) months, and is considered Cured, the condition shall no longer be considered a Pre-existing Condition.

  • You must arrange for a Veterinarian to examine and treat Your Pet as soon as possible after it shows Clinical Signs of Injury.

  • You must get a Vet to examine and treat Your Pet as soon as possible after it shows Clinical Signs of an Injury or an Illness.

  • If no amount is collected in excess of the accounts payable assumed no obligation exists to Xx. Xxxxxx for his services.

  • The cost of nasal fold, skin fold, stenotic nares and soft palate resections, enlarged tongue (macroglossa), everted laryngeal saccules, Gastrointestinal Tract and Brachycephalic Airway Obstruction (BOAS), that occur in the first twelve (12) months of cover including free cover policy, regardless of Your Pet showing Clinical Signs of the Condition or not, prior to commencement of cover or within the twenty-one (21) day Waiting Period.23.

  • Subject to the renewal of the Policy and premiums paid on time, We will pay up to the Maximum Benefit in total for the costs of Treatment of Your Pet for all Injuries or Illnesses for a maximum of 12 Months from and including the date during the Period of Insurance on which an Injury occurred or the date during the Period of Insurance on which the first Clinical Signs of an Illness manifested.

  • Clinical Signs and Symptoms of Anaphylaxis Anaphylaxis is a serious, acute, allergic reaction that may cause death.

  • Orthopedic Accidents and Illnesses occurring or showing Clinical Signs during the Orthopedic Waiting Period, even if the Accident Waiting Period is complete.


More Definitions of Clinical Signs

Clinical Signs means any changes to your Pet’s normal healthy state, behaviour or bodily functions.
Sample 1Sample 2
Clinical Signs means a change/s in your Pet’s normal healthy state, its bodily functions and/ or its behaviour.
Sample 1
Clinical Signs means: Changes in Your Pet’s normal healthy state, bodily functions, or behavior as observed by any individual and recorded in Your Pet’s medical records unless caused by an Accident or Illness.
Sample 1
Clinical Signs means a visible or detectable change in the pet’s normal healthy state, condition, appearance or bodily function.
Sample 1
Clinical Signs means changes in the normal healthy state, bodily function, or behavior of Your Pet observed by You, a Veterinarian, or other observer.
Sample 1

Related to Clinical Signs

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical Data means the information with respect to the Licensed Product or the Licensed Compound made, collected or otherwise generated under or in connection with pre-clinical, clinical, or the post-Approval studies for the Licensed Compound or Licensed Product, including any data, reports and results with respect to any of the foregoing.

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Medical cannabis pharmacy means the same as that term is defined in Section 26-61a-102.

  • Marijuana products means concentrated marijuana products and marijuana products that are comprised of marijuana and other ingredients and are intended for use or consumption, such as, but not limited to, edible products, ointments, and tinctures.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical staff means persons who work in a hospital whose duties include the personal care or medical treatment of patients. “Clinical staff” includes, but is not limited to, credentialed physicians, physicians’ assistants, nurses, nursing aides, medical technicians, therapists, and other individuals involved in the personal care or medical treatment of patients.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Clinical Study means a Xxxxx 0 Xxxxx, Xxxxx 2 Study, Phase 3 Study, Post-Marketing Study, Supplemental Study or other study (including a non-interventional study) in humans to obtain information regarding the product, including information relating to the safety, tolerability, pharmacological activity, pharmacokinetics, dose ranging or efficacy of the product.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Licensed clinical social worker means an individual who meets the licensed clinical social worker requirements established in KRS 335.100.

  • Clinical Development means the conduct of clinical trials in humans to assess the dosing, safety and/or efficacy of the Product, including but not limited to Phase I Clinical Trials, Phase II Clinical Trials, Phase Ill Clinical Trials and Phase IV Clinical Trials.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.